All | E-CS | E-CPR | |
---|---|---|---|
Patients, n (%) | 90 (100) | 50 (55.6) | 40 (44.4) |
Age (years), mean (SD) | 58.8 (15.8) | 60.0 (16.0) | 57.4 (15.6) |
Gender | |||
Male, n (%) | 64 (71.1) | 34 (68.0) | 30 (75.0) |
Female, n (%) | 26 (28.9) | 16 (32.0) | 10 (25.0) |
BMI, mean (SD) | 30.7 (6.96) | 29.1 (7.28) | 32.9 (5.93) |
Race | |||
White, n (%) | 43 (47.8) | 24 (48.0) | 19 (47.5) |
Black, n (%) | 16 (17.8) | 9 (18.0) | 7 (17.5) |
Asian, n (%) | 13 (14.4) | 8 (16.0) | 5 (12.5) |
Other, n (%) | 18 (20.0) | 9 (18.0) | 9 (22.5) |
Transfers, n (%) | 40 (44.4) | 30 (60.0) | 10 (25.0) |
Dual MCS therapy (Impella, IABP) | 34 (37.8) | 25 (50.0) | 9 (22.5) |
Diabetes, n (%) | 33 (36.7) | 17 (34.0) | 16 (40.0) |
Hypertension, n (%) | 59 (65.6) | 31 (62.0) | 28 (70.0) |
Hyperlipidemia, n (%) | 39 (43.3) | 23 (46.0) | 16 (40.0) |
Congestive heart failure, n (%) | 20 (22.2) | 14 (28.0) | 6 (15.0) |
Peripheral vascular disease, n (%) | 8 (8.9) | 6 (12.0) | 2 (5.0) |
Coronary artery disease, n (%) | 56 (62.2) | 31 (62.0) | 25 (62.5) |
Chronic obstructive pulmonary disease, n (%) | 7 (7.8) | 4 (8.0) | 3 (7.5) |
CKD/ESRD, n (%) | 12 (13.3) | 9 (18.0) | 3 (7.5) |
Past myocardial infarction, n (%) | 21 (23.3) | 11 (22.0) | 10 (25.0) |
Past cerebrovascular accident, n (%) | 10 (11.1) | 8 (16.0) | 2 (5.0) |
Smoking, n (%) | 22 (24.4) | 11 (22.0) | 11 (27.5) |
Ventilator support, n (%) | 69 (76.7) | 35 (70.0) | 34 (85.0) |
AKI/ RF (prior to ECMO initiation), n (%) | 12 (13.3) | 10 (20.0) | 2 (5.0) |